Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  MDxHealth    MDXH   BE0003844611

MDXHEALTH

(MDXH)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
0.976(c) 0.885(c) 0.905(c) 1.1(c) 1.3(c) Last
682 281 714 231 425 696 1 777 983 2 264 573 Volume
-4.31% -9.32% +2.26% +21.55% +18.18% Change
More quotes
Financials (EUR)
Sales 2018 29,7 M
EBIT 2018 -23,3 M
Net income 2018 -23,2 M
Finance 2018 26,2 M
Yield 2018 -
Sales 2019 37,8 M
EBIT 2019 -12,7 M
Net income 2019 -12,7 M
Finance 2019 23,6 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 1,75x
EV / Sales2019 1,44x
Capitalization 78,0 M
More Financials
Company
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The activity is organized around two product families: - Clinical Molecular Diagnostics (ClinicalMDx)... 
More about the company
Surperformance© ratings of MDxHealth
Trading Rating : Investor Rating :
More Ratings
Latest news on MDXHEALTH
02/16MDXHEALTH (R) : MDxHealth Announces Presentation of Positive Data for SelectMDx ..
AQ
02/15MDXHEALTH (R) : MDxHealth Announces Presentation of Positive Data for SelectMDx ..
GL
02/14MDXHEALTH : Signs Partnership with LifeLabs to Make SelectMDx Available in Canad..
AQ
02/14MDXHEALTH (R) : MDxHealth Signs Partnership with LifeLabs to Make SelectMDx avai..
PU
02/14MDXHEALTH (R) : MDxHealth Signs Partnership with LifeLabs to Make SelectMDx ava..
AQ
02/11MDXHEALTH : - MDxHealth : Shareholder Transparency Declaration
AQ
02/08MDXHEALTH (R) : MDxHealth Shareholder Transparency Declaration
GL
01/24MDXHEALTH (R) : SelectMDx Outperforms Prostate Health Index (phi) Blood Test for..
GL
01/16MDXHEALTH : - MDxHealth : Provides Business Update
AQ
01/14MDXHEALTH (R) : MDxHealth Provides Business Update
AQ
More news
Analyst Recommendations on MDXHEALTH
More recommendations
Sector news : Biotechnology & Medical Research - NEC
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06Eli Lilly Cuts Earnings Forecast on Pending Loxo Acquisition
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart MDXHEALTH
Duration : Period :
MDxHealth Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MDXHEALTH
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 4,07 €
Spread / Average Target 213%
EPS Revisions
Managers
NameTitle
Jan Groen President, CEO & Executive Director
Koen Hoffman Chairman
Jean-Marc Roelandt Chief Financial Officer & Executive Vice President
Michael K. Brawer Chief Medical Officer & Executive Vice President
Rudi M. Mariën Non-Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MDXHEALTH-29.73%88
IQVIA HOLDINGS INC11.13%28 377
CELLTRION, INC.--.--%23 803
LONZA GROUP14.80%21 653
INCYTE CORPORATION31.18%17 908
SEATTLE GENETICS, INC.17.42%11 477